Potential bias in ophthalmic pharmaceutical clinical trials
Paul VarnerJohn J Pershing Veterans’ Administration Medical Center, Poplar Bluff, Missouri, USAAbstract: To make clinicians aware of potential sources of error in ophthalmic pharmaceutical clinical trials that can lead to erroneous interpretation of results, a critical review of the st...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2008-06-01
|
| Series: | Clinical Ophthalmology |
| Online Access: | http://www.dovepress.com/potential-bias-in-ophthalmic-pharmaceutical-clinical-trials-a1795 |
| id |
doaj-12c8bb65eba64033ac521bbd993f403b |
|---|---|
| record_format |
Article |
| spelling |
doaj-12c8bb65eba64033ac521bbd993f403b2020-11-24T22:58:28ZengDove Medical PressClinical Ophthalmology1177-54671177-54832008-06-012008Issue 2401411Potential bias in ophthalmic pharmaceutical clinical trialsPaul VarnerPaul VarnerJohn J Pershing Veterans’ Administration Medical Center, Poplar Bluff, Missouri, USAAbstract: To make clinicians aware of potential sources of error in ophthalmic pharmaceutical clinical trials that can lead to erroneous interpretation of results, a critical review of the study design of various pharmaceutical ophthalmic clinical trials was completed. Discrepancies as a result of study shortcomings may explain observed differences between reported ophthalmic trial data and observed clinical results.Keywords: evidence-based medicine, validity, bias, gold standard http://www.dovepress.com/potential-bias-in-ophthalmic-pharmaceutical-clinical-trials-a1795 |
| collection |
DOAJ |
| language |
English |
| format |
Article |
| sources |
DOAJ |
| author |
Paul Varner |
| spellingShingle |
Paul Varner Potential bias in ophthalmic pharmaceutical clinical trials Clinical Ophthalmology |
| author_facet |
Paul Varner |
| author_sort |
Paul Varner |
| title |
Potential bias in ophthalmic pharmaceutical clinical trials |
| title_short |
Potential bias in ophthalmic pharmaceutical clinical trials |
| title_full |
Potential bias in ophthalmic pharmaceutical clinical trials |
| title_fullStr |
Potential bias in ophthalmic pharmaceutical clinical trials |
| title_full_unstemmed |
Potential bias in ophthalmic pharmaceutical clinical trials |
| title_sort |
potential bias in ophthalmic pharmaceutical clinical trials |
| publisher |
Dove Medical Press |
| series |
Clinical Ophthalmology |
| issn |
1177-5467 1177-5483 |
| publishDate |
2008-06-01 |
| description |
Paul VarnerJohn J Pershing Veterans’ Administration Medical Center, Poplar Bluff, Missouri, USAAbstract: To make clinicians aware of potential sources of error in ophthalmic pharmaceutical clinical trials that can lead to erroneous interpretation of results, a critical review of the study design of various pharmaceutical ophthalmic clinical trials was completed. Discrepancies as a result of study shortcomings may explain observed differences between reported ophthalmic trial data and observed clinical results.Keywords: evidence-based medicine, validity, bias, gold standard |
| url |
http://www.dovepress.com/potential-bias-in-ophthalmic-pharmaceutical-clinical-trials-a1795 |
| work_keys_str_mv |
AT paulvarner potentialbiasinophthalmicpharmaceuticalclinicaltrials |
| _version_ |
1725647062251339776 |